Biotech · Private company
Kriya Therapeutics, Inc.
Track this companyFree. Adds Kriya Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Sham (No Treatment)Phase 2 · Thyroid Eye Disease (TED)ClinicalTrials.gov · fetched Nov 12, 2026
- VV-14295Phase 2 · Geographic Atrophy Secondary to Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- VV-14303Phase 2 · Metabolic Dysfunction-associated Steatohepatitis (MASH)ClinicalTrials.gov · fetched Nov 12, 2026
- VV-14305Phase 2 · Thyroid Eye Disease (TED)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)PHASE1_PHASE2 · RECRUITING · started Jul 30, 2026ClinicalTrials.gov NCT07732400 · fetched Nov 12, 2026
- A Study of VV-14305 for the Treatment of Thyroid Eye DiseasePHASE1_PHASE2 · RECRUITING · started May 1, 2026ClinicalTrials.gov NCT07404111 · fetched Nov 12, 2026
- A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular DegenerationPHASE1_PHASE2 · RECRUITING · started May 28, 2025ClinicalTrials.gov NCT06765980 · fetched Nov 12, 2026